Press "Enter" to skip to content

Strides board approves USD 15 mn investment in Stelis Biopharma

The company’s board has approved participation in the Series B fundraiser of Stelis Biopharma with a commitment of USD 15 million, Strides Pharma Science said in a regulatory filing.

Original source: https://health.economictimes.indiatimes.com/news/pharma/strides-board-approves-usd-15-mn-investment-in-stelis-biopharma/66759182?utm_source=RSS&utm_medium=ETRSS

Also Read:   Covaxin trials for kids likely soon in Nagpur